Patent Assignment
Reel/Frame 023951/0611
Corrective Assignment to Correct the Spelling of Assignor's Name and to Correct the Name of the Assignee Previously Recorded on Reel 023869 Frame 0734. Assignor(S) Hereby Confirms the Assignor's Name Should Have Been: Michael Ankersen; and the Assignee's Name Should Have Been: Novo Nordisk A/S.
Recorded: 2010-02-01
Pages: 6
Assignor
ANKERSEN, MICHAEL
Executed: 2010-01-29
Assignee
NOVO NORDISK A/S
100 COLLEGE ROAD WEST, PRINCETON, NEW JERSEY, 08540
Covered Property
(1)
Growth Hormone Secretagogue Receptor Type 1A Agonists
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 20, 2006
From: ANDERSEN, MAIBRITT BANSHOLM; HANSEN, BIRGIT SEHESTED; RAUN, KIRSTEN; TULLIN, SOREN
To: NOVO NORDISK A/S
Reel/Frame 018556/0043 →
Assignment of Assignor's Interest
Feb 18, 2009
From: NOVO NORDISK A/S
To: SAPPHIRE THERAPEUTICS
Reel/Frame 022277/0160 →
Merger
Jan 14, 2010
From: SAPPHIRE THERAPEUTICS, INC.
To: HELSINN THERAPEUTICS (U.S.), INC.
Reel/Frame 023778/0301 →
Merger
Jan 29, 2010
From: SAPPHIRE THERAPEUTICS, INC.
To: HELSINN THERAPEUTICS (U.S.), INC.
Reel/Frame 023869/0787 →
Assignment of Assignor's Interest
Jan 29, 2010
From: ANKERSON, MICHAEL
To: HELSINN THERAPEUTICS (U.S.), INC.
Reel/Frame 023869/0734 →
Assignment of Assignor's Interest
Oct 28, 2015
From: HELSINN THERAPEUTICS (U.S.), INC.
To: HELSINN HEALTHCARE SA
Reel/Frame 036903/0809 →
Corrective Assignment to Correct the Country of the Assignee's Address Previously Recorded on Reel 036903 Frame 0809. Assignor(S) Hereby Confirms the Correct Country of the Assignee's Address.
Dec 14, 2015
From: HELSINN THERAPEUTICS (U.S.), INC.
To: HELSINN HEALTHCARE SA
Reel/Frame 037288/0749 →